Satyam N. Patel
Satyam N. Patel has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Laxit K. Bhatt
Department of Pharmacology and Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Ahmedabad, India
6 shared publications - Mukul R. Jain
Department of Pharmacology and Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Ahmedabad, India
6 shared publications - Chetan K. Kajavadara
Department of Pharmacology and Toxicology, Zydus Research Centre Zydus Lifesciences Limited Ahmedabad India
5 shared publications Rajesh Sundar
Department of Pharmacology and Toxicology, Zydus Research Centre Zydus Lifesciences Limited Ahmedabad India
5 shared publications- Rushikesh M. Shukla
Department of Pharmacology and Toxicology, Zydus Research Centre Zydus Lifesciences Limited Ahmedabad India
4 shared publications Darshan T. Valani
Zydus Research Center
3 shared publications
Latest Publications
- 9 May 2026
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 435, 112135
Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar rats
- 9 May 2026
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 435, 112135
Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar rats
- 18 August 2025
- Published by Wiley in Journal of Applied Toxicology
- Vol. 46 (2) , 469-478
Evaluating Solvent Safety in Chromosome Aberration Assays for Genetic Toxicology
The chromosome aberration test (CAT) is a widely used in vitro assay for detecting structural chromosomal damage induced by clastogenic chemicals. It plays a crucial role in genetic toxicology, helping assess the potential genotoxic effects of pharmaceutical compounds, environmental contaminants, and industrial chemicals. This test is particularly valuable in regulatory studies, as chromosomal aberrations are linked to mutagenicity, carcinogenicity, and hereditary diseases. The test evaluates their occurrence in cultured human peripheral blood lymphocytes (HPBL) or other mammalian cells after exposure to test chemicals. Accurate solubility of test compounds is critical for determining the highest feasible concentration in CAT without compromising cell viability or assay integrity. However, selecting an appropriate solvent remains a challenge in genetic toxicology, as the solvent must ensure chemical stability, support cell growth and metabolic activation, comprise ≤ 1% of the final treatment medium, and be compatible with human blood cells. In this study, we systematically evaluated the cytotoxic effects of various solvents on HPBL at 0.5% and 1% concentrations over a 22‐h exposure period, replicating approximately 1.5 normal cell cycle durations without the inclusion of a metabolic activation system. The solvents tested included dimethyl sulfoxide (DMSO), N , N ‐dimethylformamide (DMF), acetone, acetonitrile, ethyl acetate, ethanol, methanol, p ‐dioxane, tetrahydrofuran (THF), and dimethylacetamide. Our findings revealed that N , N ‐dimethylformamide and acetone were noncytotoxic at 0.5%, while ethanol, methanol, acetonitrile, and dimethyl sulfoxide were noncytotoxic at both 0.5% and 1% concentrations, whereas other solvents exhibited cytotoxic effects at both concentrations. These findings provide valuable insights for genetic toxicologists, enabling better selection of optimal solvents for CAT‐based genotoxicity assessments. By refining solvent choices, researchers can improve chromosome aberration analysis accuracy, facilitating more reliable regulatory decision‐making in genetic toxicology and pharmaceutical safety evaluations.
- 18 August 2025
- Published by Wiley in Journal of Applied Toxicology
- Vol. 46 (2) , 469-478
Evaluating Solvent Safety in Chromosome Aberration Assays for Genetic Toxicology
The chromosome aberration test (CAT) is a widely used in vitro assay for detecting structural chromosomal damage induced by clastogenic chemicals. It plays a crucial role in genetic toxicology, helping assess the potential genotoxic effects of pharmaceutical compounds, environmental contaminants, and industrial chemicals. This test is particularly valuable in regulatory studies, as chromosomal aberrations are linked to mutagenicity, carcinogenicity, and hereditary diseases. The test evaluates their occurrence in cultured human peripheral blood lymphocytes (HPBL) or other mammalian cells after exposure to test chemicals. Accurate solubility of test compounds is critical for determining the highest feasible concentration in CAT without compromising cell viability or assay integrity. However, selecting an appropriate solvent remains a challenge in genetic toxicology, as the solvent must ensure chemical stability, support cell growth and metabolic activation, comprise ≤ 1% of the final treatment medium, and be compatible with human blood cells. In this study, we systematically evaluated the cytotoxic effects of various solvents on HPBL at 0.5% and 1% concentrations over a 22‐h exposure period, replicating approximately 1.5 normal cell cycle durations without the inclusion of a metabolic activation system. The solvents tested included dimethyl sulfoxide (DMSO), N , N ‐dimethylformamide (DMF), acetone, acetonitrile, ethyl acetate, ethanol, methanol, p ‐dioxane, tetrahydrofuran (THF), and dimethylacetamide. Our findings revealed that N , N ‐dimethylformamide and acetone were noncytotoxic at 0.5%, while ethanol, methanol, acetonitrile, and dimethyl sulfoxide were noncytotoxic at both 0.5% and 1% concentrations, whereas other solvents exhibited cytotoxic effects at both concentrations. These findings provide valuable insights for genetic toxicologists, enabling better selection of optimal solvents for CAT‐based genotoxicity assessments. By refining solvent choices, researchers can improve chromosome aberration analysis accuracy, facilitating more reliable regulatory decision‐making in genetic toxicology and pharmaceutical safety evaluations.
- 2 July 2025
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 117, 104752
Strain-specific mutagenicity of NDMA and CPNP: insights from TA1535, TA100, and WP2 uvrA (pKM101) under metabolic activation
- 2 July 2025
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 117, 104752
Strain-specific mutagenicity of NDMA and CPNP: insights from TA1535, TA100, and WP2 uvrA (pKM101) under metabolic activation
- 8 June 2025
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 66 (5) , 291-297
Comparative Analysis of TA102 and WP2uvrA(pKM101) Strains in Detecting Nitrosamine Mutagens in the Enhanced Ames Test
The Ames test is a fundamental assay for evaluating chemical mutagenicity, particularly for nitrosamines, which are widespread environmental and pharmaceutical contaminants. To improve sensitivity, regulatory agencies have endorsed the enhanced Ames test (EAT), which incorporates five tester strains, a 30‐min pre‐incubation step, and metabolic activation using both rat and hamster liver S9 fractions. While Salmonella typhimurium TA102 is known for its sensitivity to oxidative mutagens, its performance under EAT conditions has not been fully characterized. This study evaluated the mutagenic response of TA102 using two nitrosamine positive controls: N‐nitrosodimethylamine (NDMA) and 1‐cyclopentyl‐4‐nitrosopiperazine (CPNP). E. coli WP2 uvrA(pKM101) showed consistent mutagenic responses to both NDMA and CPNP, consistent with existing EAT data. TA102 demonstrated a robust response to NDMA but not to CPNP, suggesting limited sensitivity to certain nitrosamines. These findings support the continued use of WP2 uvrA(pKM101) in EAT protocols and highlight the limited utility of TA102 for comprehensive nitrosamine mutagenicity assessment.
- 8 June 2025
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 66 (5) , 291-297
Comparative Analysis of TA102 and WP2uvrA(pKM101) Strains in Detecting Nitrosamine Mutagens in the Enhanced Ames Test
The Ames test is a fundamental assay for evaluating chemical mutagenicity, particularly for nitrosamines, which are widespread environmental and pharmaceutical contaminants. To improve sensitivity, regulatory agencies have endorsed the enhanced Ames test (EAT), which incorporates five tester strains, a 30‐min pre‐incubation step, and metabolic activation using both rat and hamster liver S9 fractions. While Salmonella typhimurium TA102 is known for its sensitivity to oxidative mutagens, its performance under EAT conditions has not been fully characterized. This study evaluated the mutagenic response of TA102 using two nitrosamine positive controls: N‐nitrosodimethylamine (NDMA) and 1‐cyclopentyl‐4‐nitrosopiperazine (CPNP). E. coli WP2 uvrA(pKM101) showed consistent mutagenic responses to both NDMA and CPNP, consistent with existing EAT data. TA102 demonstrated a robust response to NDMA but not to CPNP, suggesting limited sensitivity to certain nitrosamines. These findings support the continued use of WP2 uvrA(pKM101) in EAT protocols and highlight the limited utility of TA102 for comprehensive nitrosamine mutagenicity assessment.
- Open Access
- 20 February 2025
- Published by Wiley
Comparative Analysis of TA102 and WP2 uvrA (pKM101) strains in detecting nitrosamine mutagens in the enhanced Ames test
- 20 February 2025
- Published by Wiley
Open AccessComparative Analysis of TA102 and WP2 uvrA (pKM101) strains in detecting nitrosamine mutagens in the enhanced Ames test
- 13 January 2025
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 66 (1-2) , 69-76
Assessing the impact of different solvents in the bacterial reverse mutation test
The bacterial reverse mutation test is essential for identifying the mutagenic potential of chemicals. The solubility of the test substance is vital for achieving the recommended assay concentration. Preferred solvents like dimethyl sulfoxide and water are chosen for their compatibility and historical data. Selecting a compatible solvent with Salmonella typhimurium and Escherichia coli WP2 uvrA strains, considering a maximum cytotoxic concentration or the limit of 5 mg/plate, can be challenging. This study assessed various solvents, including N,N‐dimethylformamide, acetone, acetonitrile, ethyl acetate, 95% ethanol, diethylene glycol monomethyl ether, methanol, P‐dioxane, tetrahydrofuran, and dimethylacetamide, as alternative solvents in the AMES test. Results showed all solvents, except tetrahydrofuran, were compatible at concentrations up to 100 μL/plate or more, as they did not inhibit S9 enzymes, bacterial growth, or alter bacterial revertant colony counts, making them suitable for the bacterial reverse mutation test.
- 13 January 2025
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 66 (1-2) , 69-76
Assessing the impact of different solvents in the bacterial reverse mutation test
The bacterial reverse mutation test is essential for identifying the mutagenic potential of chemicals. The solubility of the test substance is vital for achieving the recommended assay concentration. Preferred solvents like dimethyl sulfoxide and water are chosen for their compatibility and historical data. Selecting a compatible solvent with Salmonella typhimurium and Escherichia coli WP2 uvrA strains, considering a maximum cytotoxic concentration or the limit of 5 mg/plate, can be challenging. This study assessed various solvents, including N,N‐dimethylformamide, acetone, acetonitrile, ethyl acetate, 95% ethanol, diethylene glycol monomethyl ether, methanol, P‐dioxane, tetrahydrofuran, and dimethylacetamide, as alternative solvents in the AMES test. Results showed all solvents, except tetrahydrofuran, were compatible at concentrations up to 100 μL/plate or more, as they did not inhibit S9 enzymes, bacterial growth, or alter bacterial revertant colony counts, making them suitable for the bacterial reverse mutation test.
- Open Access
- 30 October 2024
- Published by Wiley
Assessing the Impact of Different Solvents on Mutagenic Responses in the Ames Test
The Bacterial reverse mutation (AMES) assay is crucial for detecting the mutagenic potential of chemicals using bacterial strains. The solubility of the test substance is key to achieving the recommended concentration for the assay. DMSO and water are typically preferred solvents due to their compatibility and historical data. The chosen solvent must not react with the test substance and must support bacterial survival and S9 activity. Selecting a solvent compatible with Salmonella typhimurium and Escherichia coli WP2 uvr A strains, considering a maximum cytotoxic concentration of 5 mg/plate, is challenging for genetic toxicologists. This study evaluated various solvents, including N,N-Dimethyl formamide, Acetone, Acetonitrile, Ethyl acetate, 95% Ethanol, Dimethylene Glycol Monomethyl ether, Methanol, P-Dioxane, Tetrahydrofuran, and Dimethyl acetamide. Results showed that all solvents, except Tetrahydrofuran, were compatible up to 100 µL/plate or more, as they did not inhibit bacterial growth or alter bacterial revertant colony counts, making them suitable for use in the Ames assay.
- 30 October 2024
- Published by Wiley
Open AccessAssessing the Impact of Different Solvents on Mutagenic Responses in the Ames Test
The Bacterial reverse mutation (AMES) assay is crucial for detecting the mutagenic potential of chemicals using bacterial strains. The solubility of the test substance is key to achieving the recommended concentration for the assay. DMSO and water are typically preferred solvents due to their compatibility and historical data. The chosen solvent must not react with the test substance and must support bacterial survival and S9 activity. Selecting a solvent compatible with Salmonella typhimurium and Escherichia coli WP2 uvr A strains, considering a maximum cytotoxic concentration of 5 mg/plate, is challenging for genetic toxicologists. This study evaluated various solvents, including N,N-Dimethyl formamide, Acetone, Acetonitrile, Ethyl acetate, 95% Ethanol, Dimethylene Glycol Monomethyl ether, Methanol, P-Dioxane, Tetrahydrofuran, and Dimethyl acetamide. Results showed that all solvents, except Tetrahydrofuran, were compatible up to 100 µL/plate or more, as they did not inhibit bacterial growth or alter bacterial revertant colony counts, making them suitable for use in the Ames assay.
- 10 October 2024
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 154, 105711
Selection of solvent and positive control concentration for enhanced Ames test conditions for N-nitrosamine compounds
- 10 October 2024
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 154, 105711
Selection of solvent and positive control concentration for enhanced Ames test conditions for N-nitrosamine compounds